Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • New symptom may help identify sleep apnea in older women

  • Feeling blue and seeing blue: Sadness may impair color perception

  • Risk of cognitive impairment in children born prematurely may be predicted using MRI after birth

  • Language acquisition: From sounds to the meaning

  • Forensic examiners pass the face matching test

  • Bisexual and questioning women have higher risk of eating disorders

  • Psychological consequences remain profound in coastal areas of Tohoku

  • How anesthesia may fight lung infections: Mouse study

  • Researchers develop a likely new combo treatment for the deadliest form of brain cancer

  • Antipsychotics inappropriately prescribed to people with intellectual disabilities

  •